Growing Role in Biosimilar Development
The rise of biosimilars has significantly increased the demand for the Bioanalytical Testing Services Market. Biosimilars, being highly similar to already approved biologics, require extensive comparative testing to ensure safety, efficacy, and structural integrity. Specialized bioanalytical techniques are essential to demonstrate molecular equivalence and meet regulatory approval standards.
Service providers are expanding their offerings to include advanced comparability studies, stability testing, and immunogenicity assessments. This growing focus on biosimilars is opening new opportunities for market growth, especially in emerging economies with expanding healthcare access.